CTLA Antibodies

Santa Cruz Biotechnology features a diverse variety of CTLA Antibodies for research in immunology and cancer biology. CTLA Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) plays a critical role in regulating immune responses by acting as an inhibitory receptor on T cells. CTLA-4 function is essential for maintaining immune homeostasis and preventing autoimmunity, making it a significant target in cancer immunotherapy. The modulation of CTLA-4 activity has been shown to enhance anti-tumor immunity, highlighting its importance in the development of therapeutic strategies. Researchers can investigate immune checkpoint pathways and their impact on T cell responses using specific monoclonal antibodies. Understanding CTLA-4 signaling mechanisms helps advance knowledge in autoimmune disorders and cancer treatments. Exploring CTLA-4's role in immune regulation continues to reveal new therapeutic possibilities. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of immune checkpoint regulation and contribute to the development of innovative cancer treatments.